Author

Tetsuya Tohge

Observed names: T Tohge, T. Tohge, Tohge, T

Observed institution: Hiroshima University

OpenAlex ID: A5008045189

Clinical studies on streptococcal preparation (OK-432) combined with mitomycin-C, 5-FU and cytosine arabinoside in advanced cancer patients

1975 · Takao Hattori, Minoru Niimoto, et al. · Surgery Today · 5

[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study for postmenopausal women with advanced or recurrent breast cancer (no. 1)--investigation of recommended clinical dose CGS20267 Study Group].

2002 · Rikiya Abe, Takeshi Tominaga, et al. · PubMed · 4

[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study in postmenopausal women with advanced or recurrent breast cancer (no. 2)--evaluation of efficacy and safety at the recommended clinical dose CGS20267 Study Group].

2002 · Izo Kimijima, Takeshi Tominaga, et al. · PubMed · 2

[CGS 20267 (Letrozole), a new aromatase inhibitor: early phase II study for postmenopausal women with advanced breast cancer].

2002 · Yasuo Nomura, Takeshi Tominaga, et al. · PubMed · 1

[In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].

1987 · M Nishiyama, K Niimi, et al. · PubMed

Ok-432 administration in mice.

1976 · Hattori, T, Niimoto, M, et al. · The Mouseion at the JAXlibrary (Jackson Laboratory)

Clinical and Experimental Studies on Immunochemotherapy Using OK-432, A New Streptococcal Preparation

1976 · T. Hattori, M. Niimoto, et al. · Springer eBooks

Works count: 7

Citation count: 12

H-index: 2

I10-index: